139
Participants
Start Date
March 9, 2017
Primary Completion Date
March 12, 2021
Study Completion Date
December 31, 2023
Olaparib
Tablet, 100mg and 150mg
Cediranib
Tablet 15mg and 20mg
Paclitaxel
Intravenous (IV)
Belfast City Hospital, Belfast
Mount Vernon Cancer Centre, Northwood
Royal United Hospital, Bath
Velindre, Cardiff
Beatson West of Scotland Cancer Centre, Glasgow
Clatterbridge Cancer Centre, Liverpool
Royal Marsden Chelsea & Sutton, London
University College London, London
The Christie, Manchester
City Hospital Nottingham, Nottingham
Royal Surrey County Hospital, Guildford
St Bartholomew's, London
Hammersmith Hospital, London
Churchill Hospital, Oxford
Collaborators (1)
AstraZeneca
INDUSTRY
University of Oxford
OTHER